Inhibition of GSDMD-dependent pyroptosis decreased methamphetamine self-administration in rats
Brain, Behavior, and Immunity · 2024
DOI: 10.1016/j.bbi.2024.05.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2024. Verfasst von Yao Shen und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Health Science Center, Ningbo University, Ningbo, 315021, China. Hauptthemen laut MEDLINE: Methamphetamine, Pyroptosis, Self Administration, Phosphate-Binding Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Ningbo University, National Natural Science Foundation of China, Ningbo Municipal Natural Science Foundation.
Abstract (Originalsprache)
It is widely believed that the activation of the central dopamine (DA) system is crucial to the rewarding effects of methamphetamine (METH) and to the behavioral outcomes of METH use disorder. It was reported that METH exposure induced gasdermin D (GSDMD)-dependent pyroptosis in rats. The membrane pore formation caused by METH-induced pyroptosis may also contribute to the overflow of DA into the extracellular space and subsequently increase the DA levels in the brain. The present study firstly investigated whether the membrane pore information induced by GSDMD-dependent pyroptosis was associated with the increased DA levels in the ventral tegmental area (VAT) and nucleus accumbens (NAc) of rats self-administering METH and SY-SH5Y cells treated by METH. Subsequently, the effect of pore formation blockade or genetic inhibition of GSDMD on the reinforcing and motivational effect of METH was determined in rats, using the animal model of METH self-administration (SA). METH exposure significantly increased the activity of NLRP1/Cas-1/GSDMD pathway and the presence of pyroptosis, accompanied by the significantly increased DA levels in VTA and NAc. Moreover, intraperitoneal injections of disulfiram (DSF) or microinjection of rAAV-shGSDMD into VTA/NAc significantly reduced the reinforcing and motivational effect of METH, accompanied by the decreased level of DA in VTA and NAc. The results provided novel evidence that METH-induced pyroptosis could increase DA release in VTA and NAc via the NLRP1/Cas-1/GSDMD pathway. Additionally, membrane pores or GSDMD blockade could significantly reduce the reinforcing and motivational effect of METH. In conclusion, blocking GSDMD and membrane pore formation could be a promising potential target for the development of agents to treat METH use disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Health Science Center, Ningbo University, Ningbo, 315021, China.
- Department of Psychology, Collage of Teacher Education, Ningbo University, Ningbo, China.
- School of Pharmacy, Health Science Center, Ningbo University, Ningbo 315211, China.
- School of Materials Science and Chenical Engineering, Ningbo University, Ningbo 315211, China.
- School of Pharmacy, Health Science Center, Ningbo University, Ningbo 315211, China. Electronic address: liuyu@nbu.edu.cn.
Förderung
- Ningbo University
- National Natural Science Foundation of China
- Ningbo Municipal Natural Science Foundation
Zitieren
APA
Shen, Y., Gong, X., Qian, L., Ruan, Y., Lin, S., Yu, Z., Si, Z., Wei, W., & Liu, Y. (2024). Inhibition of GSDMD-dependent pyroptosis decreased methamphetamine self-administration in rats. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2024.05.040
Vancouver
Shen Y, Gong X, Qian L, Ruan Y, Lin S, Yu Z, et al. Inhibition of GSDMD-dependent pyroptosis decreased methamphetamine self-administration in rats. Brain, Behavior, and Immunity. 2024. doi:10.1016/j.bbi.2024.05.040
BibTeX
@article{Shen2024,
author = {Shen, Yao and Gong, Xinshuang and Qian, Liyin and Ruan, Yuer and Lin, Shujun and Yu, Zhaoying and Si, Zizhen and Wei, Wenting and Liu, Yu},
title = {Inhibition of GSDMD-dependent pyroptosis decreased methamphetamine self-administration in rats},
journal = {Brain, Behavior, and Immunity},
year = {2024},
doi = {10.1016/j.bbi.2024.05.040}
}
EUVIMED